Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.50
Ask: 3.80
Change: 0.10 (3.03%)
Spread: 0.30 (8.571%)
Open: 3.40
High: 3.65
Low: 3.33
Prev. Close: 3.30
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Oct 2023 15:03

RNS Number : 2722Q
Allergy Therapeutics PLC
16 October 2023
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Allergy Therapeutics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

ZQ Capital Management Limited

City and country of registered office (if applicable)

Cayman Islands

Name

Sky Gem Acquisition Limited

City and country of registered office (if applicable)

London, United Kingdom

Name

ZQ Capital Limited

City and country of registered office (if applicable)

Cayman Islands

Name

SHEN Zheqing

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

16/10/2023

6. Date on which issuer notified (DD/MM/YYYY):

16/10/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

59.959%

0.351%

60.310%

2,866,963,142

Position of previous notification (if

applicable)

25.580%

0.000%-

25.580%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00B02LCQ05

2,850,296,476

0

59.959%

0%

SUBTOTAL 8. A

2,850,296,476

59.959%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Warrant

28/02/2028

16,666,666

0.351%

SUBTOTAL 8. B 1

16,666,666

0.351%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

SHEN Zheqing (Chain 1)

ZQ Capital Management Limited

0.351%

0.351%

ZQ Skygem Investors L.P.

Skygem International Holdings Limited

Skygem UK Holding Limited

Sky Gem Acquisition Limited

59.951%

59.951%

SHEN Zheqing (Chain 2)

ZQ Capital Limited

0.007%

0.007%

SHEN Zheqing

0.002%

0.002%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

Hong Kong

Date of completion

16/10/2023

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUNRSRORURAAA
Date   Source Headline
15th Jan 20077:00 amRNSNotice of Results
12th Dec 200611:59 amRNSHolding(s) in Company
11th Dec 20063:45 pmRNSHolding(s) in Company
7th Dec 20063:12 pmRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSResearch Update
5th Dec 20062:30 pmRNSTotal Voting Rights
6th Nov 200612:12 pmRNSDirector/PDMR Shareholding
3rd Nov 20069:20 amRNSResult of AGM
2nd Nov 200611:39 amRNSDirector/PDMR Shareholding
27th Oct 200610:58 amRNSDirector/PDMR Shareholding
11th Oct 20067:00 amRNSClinical Trials
12th Sep 20067:04 amRNSFinal Results
19th Jul 20067:01 amRNSClinical update
14th Jul 20067:01 amRNSTrading Statement
7th Jul 20064:17 pmRNSDirector/PDMR Shareholding
4th Jul 20067:00 amRNSClinical update
3rd Jul 20064:08 pmRNSHolding(s) in Company
21st Jun 20067:00 amRNSClinical update
11th May 20067:02 amRNSApproval of Vaccine patent
10th May 20063:43 pmRNSDirector/PDMR Shareholding
8th May 200611:44 amRNSHolding(s) in Company
4th May 200612:06 pmRNSEGM Statement
10th Apr 20067:02 amRNSIssue of Equity
28th Mar 20064:28 pmRNSHolding(s) in Company
27th Mar 20067:01 amRNSInterim Results
24th Mar 20067:02 amRNSClinical update
16th Mar 20069:29 amRNSNotice of Results-Amendment
6th Mar 20067:03 amRNSClinical update
1st Mar 20069:30 amRNSNotice of Results
27th Feb 20061:02 pmRNSHolding(s) in Company
9th Jan 20063:32 pmRNSHolding(s) in Company
15th Dec 20057:01 amRNSDirector/PDMR Shareholding
6th Dec 20054:17 pmRNSHolding(s) in Company
2nd Dec 20057:01 amRNSClinical update
22nd Nov 20057:03 amRNSDirectorate change and update
17th Nov 20051:08 pmRNSHolding(s) in Company
14th Nov 20057:01 amRNSChange of Adviser
7th Nov 20057:00 amRNSDirectorate Change
4th Nov 20053:05 pmRNSResult of AGM
25th Oct 20052:27 pmRNSDirector/PDMR Shareholding
13th Sep 20057:01 amRNSFinal Results
24th Aug 20057:00 amRNSChange of Adviser
18th Jul 20057:01 amRNSTrading Statement
11th May 20057:00 amRNSHolding(s) in Company
10th May 20057:01 amRNSClearance for vaccine studies
3rd May 20053:04 pmRNSHolding(s) in Company
21st Apr 200512:12 pmRNSHolding(s) in Company
14th Apr 20058:59 amRNSHolding(s) in Company
21st Mar 20054:22 pmRNSHolding(s) in Company
21st Mar 20052:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.